|
(11) | EP 0 394 893 A3 |
(12) | EUROPEAN PATENT APPLICATION |
|
|
|
|
|||||||||||||||||||||||||||
(54) | Purinyl and pyrimidinyl tetrahydrofurans |
(57) Antiviral activity is exhibited by compounds having the formula
and pharmaceutically acceptable salts thereof wherein R1 is a purine or pyrimidine base or an analog thereof and R2 and R3 are independently hydrogen, -PO3H2 or - -X7, wherein X7 is hydrogen, alkyl, substituted alkyl or aryl. |